October 15, 2010 – PDA All-Day Event

October 15, 2010 All-Day Event hosted by Lilly

Event Description

The October All-Day Event will begin with registration at 8:00 am and end at approximately 4:00 pm. It will include a catered lunch at noon. (AGENDA) The following topics will be discussed: Incoming Bombshell: FDA’s New Process Validation Guidance, Process Validation – Incorporating Quality Design and Risk Management: A Case Study, A Case Study of Process Development for a Lyophilized Vial (Manufacturing Process: Lab Trials, Up-Scaling, Clinical Manufacturing, and Process Validation), A Case Study on Registration and Stability Batches of a Biologic Drug Product, and Current Trends in Process Validation. Click here for details and list of presenters.

Registration will end on Friday, October 8, 2010.

REGISTER INDIVIDUAL

REGISTER MULTIPLE

Enhanced by Zemanta

Eli Lilly Rolls Out Diagnostics Division

…”Diagnostics division to help drugmaker tailor treatments.”

Eli Lilly has created a new division to produce tests that will “winnow out the patients most likely to benefit from a Lilly drug.” This new concept of “personalized medicine” recognizes the reality that most drugs work in only about 1/3 of the patients who take them. These new tests will help Lilly identify the subgroups of patients who will benefit the most and at what dose. The diseases that this new Lilly division will be focusing on are Cancer and Alzheimer’s.

Will there be a trend for the life sciences industry that will push pharma companies to develop diagnostic tests alongside their experimental drugs? Terry Hisey, leader of the US life sciences practice, Deloitte Consulting, believes there will be.

Enhanced by Zemanta

July 23, 2010 – Power Breakfast IBJ: Life Sciences

Power Breakfast IBJ: Life Sciences

July 23, 2010, 7:45AM
Marriott, Downtown

Individual Seating: $35
Corporate Table of Ten: $700

Featured Panelists include:

  • Anthony T. Armstrong, President & CEO of Indiana University Research and Technology Corp.
  • Andrew Cothrel, President & CEO, SONARMED, Inc.
  • Christofer Matney, Air Service Director, Indianapolis Airport Authority
  • Bart Peterson, Sr VP, Corporate Affairs and Communications, Eli Lilly

Learn more about the IBJ Power Breakfast.

Reblog this post [with Zemanta]

Life Sciences Niche Growing in Indianapolis?

According to the Indianapolis Region Guide 2010 put out by the IBJ, there’s more to Indiana Life Sciences than Eli Lilly, Dow AgroSciences, Cook Group, and Roche. In fact, Indianapolis has been attracting less known companies who are taking advantage of the great research universities, workforce, business climate, and commitment to life sciences growth.

AIT Laboratories, headquartered in Indianapolis, has more than 365 employees nationwide and hired roughly 180 employees in 2009. AIT increased their revenues by more than 75% and nearly doubled its national sales staff to 50 while also entering into 15 new markets.

Beckman Coulter is creating a center for excellence in Indianapolis. They’ve been in Indianapolis since 2006 and have about 450 people on site. In 2010 they will be adding roughly another 100 and increasing their footprint to 228K sq ft from 100K sq ft.

Reblog this post [with Zemanta]

May 11, 2010 – Finding a strategic partner to take your product to market

Finding a strategic partner to take your product to market

Where: Riley Outpatient Center (Directions)
When: 5/11/2010 at 5pm

Learn how a strategic partner can help take your medical product to market. Email jabartek@prf.org for Jim Pearson’s slides from April. Cost is free, but registration is required.

Click to Register

Speaker(s):
Wade Lange, ImmuneWorks
Gary Noonan, Eli Lilly
Matt Call, Endocyte

Moderator(s):
Jack Pincus, Selican

Reblog this post [with Zemanta]

Interview with Jena Ringo of Medivative Technologies

Interview with Jena Ringo of Medivative Technologies

Jena Ringo

Jena Ringo

CQ: Tell me about Mediviative Technologies.

Jena: Medivative Technologies, LLC was established in 2002 as a contract manufacturer for the life sciences industry. As a wholly-owned subsidiary of Aircom Manufacturing, Inc., our company draws upon Aircom’s 45 years of experience in metal fabrication, injection molding, tooling, electro-mechanical manufacturing, assembly, design and development, testing, calibration, and packaging. Aircom’s core capabilities provide Medivative with the advantage of operating at a low-overhead facility while using GMP-compliant processes and approaches to medical device manufacturing.

CQ: What do you do?

Jena: I’m a project manager at Medivative Technologies.

CQ: What three words describe Medivative?

Jena: Full Contract Manufacturer.

Reblog this post [with Zemanta]

March 11, 2010 – Strategic Sourcing of Discovery and Development in Pharma

Strategic Sourcing of Discovery and Development in Pharma:  Past, Present, and Future

Speaker: Dr. Andrew Dahlem, VP LRL Operations / LRL Europe from Eli Lilly & Co.

When: 5:30P Thursday, March 11, 2010

Where: The Conrad Indianapolis

For more information, please contact:

Daisy Hartman
Eli Lilly & Co.
317.655.6832